You are here

งานวิจัย 10 อันดับที่ถูกอ้างอิงมากที่สุด

Top-10 Most Cited Articles- Faculty of Medicine Ramathibodi Hospital, Mahidol University

Document title Authors Year Source Cited by
1. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: A case-control study Yusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M.G., Commerford, P., Lang, C.C., Rumboldt, Z., Onen, C.L., Lisheng, L., Tanomsup, S., Wangai Jr., P., Razak, F., Sharma, A.M., Anand, S.S. 2005 Lancet, 366 (9497) , pp. 1640-1649. 1899
2. A new approach for catheter ablation of atrial fibrillation: Mapping of the electrophysiologic substrate Nademanee, K., McKenzie, J., Kosar, E., Schwab, M., Sunsaneewitayakul, B., Vasavakul, T., Khunnawat, C., Ngarmukos, T. 2004  Journal of the American College of Cardiology, 43 (11) , pp. 2044-2053. 1513
3. Sarcopenia in Asia: Consensus report of the Asian working group for sarcopenia Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K.S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., Lee, J.S.W., Lee, W.-J., Lee, Y., Liang, C.-K., Limpawattana, P., Lin, C.-S., Peng, L.-N., Satake, S., Suzuki, T., Won, C.W., Wu, C.-H., Wu, S.-N., Zhang, T., Zeng, P., Akishita, M., Arai, H. 2014 Journal of the American Medical Directors Association, 15 (2) , pp. 95-101. 1008
4. Effect of nesiritide in patients with acute decompensated heart failure O'Connor C.M., Starling R.C., Hernandez A.F., Armstrong P.W., Dickstein K., Hasselblad V., Heizer G.M., (...), Califf R.M. 2011 New England Journal of Medicine, 365 (1) , pp. 32-43. 812
5. Dronedarone in high-risk permanent atrial fibrillation Connolly S.J., Camm A.J., Halperin J.L., Joyner C., Alings M., Amerena J., Atar D., (...), Yunus A. 2011 New England Journal of Medicine, 365 (24) , pp. 2268-2276. 436
6. Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: A multicentre, randomised, double-blind phase 3 trial San-Miguel J.F., Hungria V.T.M., Yoon S.-S., Beksac M., Dimopoulos M.A., Elghandour A., Jedrzejczak W.W., (...), Richardson P.G. 2014 The Lancet Oncology, 15 (11) , pp. 1195-1206. 424
7. Prevention of ventricular fibrillation episodes in brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium Nademanee, K., Veerakul, G., Chandanamattha, P., Chaothawee, L., Ariyachaipanich, A., Jirasirirojanakorn, K., Likittanasombat, K., Bhuripanyo, K., Ngarmukos, T. 2011 Circulation, 123 (12) , pp. 1270-1279. 403
8. Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: Results from the randomized phase III BRISK-FL study Johnson, P.J., Qin, S., Park, J.-W., Poon, R.T.P., Raoul, J.-L., Philip, P.A., Hsu, C.-H., Hu, T.-H., Heo, J., Xu, J., Lu, L., Chao, Y., Boucher, E., Han, K.-H., Paik, S.-W., Robles-Aviña, J., Kudo, M., Yan, L., Sobhonslidsuk, A., Komov, D., Decaens, T., Tak, W.-Y., Jeng, L.-B., Liu, D., Ezzeddine, R., Walters, I., Cheng, A.-L. 2013 Journal of Clinical Oncology, 31 (28) , pp. 3517-3524. 388
9. Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: A randomized phase 2 trial Kantarjian, H., Pasquini, R., Hamerschlak, N., Rousselot, P., Holowiecki, J., Jootar, S., Robak, T., Khoroshko, N., Masszi, T., Skotnicki, A., Hellmann, A., Zaritsky, A., Golenkov, A., Radich, J., Hughes, T., Countouriotis, A., Shah, N. 2007 Blood, 109 (12) , pp. 5143-5150. 319
10. Vaccination greatly reduces disease, disability, death and inequity worldwide Andre, F.E., Booy, R., Bock, H.L., Clemens, J., Datta, S.K., John, T.J., Lee, B.W., Lolekha, S., Peltola, H., Ruff, T.A., Santosham, M., Schmitt, H.J. 2008 Bulletin of the World Health Organization, 86 (2) , pp. 140-146. 310

by Scopus Update data : 9 Jan 2020




หน่วยวิเคราะห์ข้อมูลและทุนวิจัย สำนักงานวิจัย วิชาการและนวัตกรรม

คณะแพทยศาสตร์โรงพยาบาลรามาธิบดี มหาวิทยาลัยมหิดล

อาคารวิจัยและสวัสดิการ ชั้น 3 ห้อง 307 เลขที่ 270 ถนนพระราม 6 พญาไท ราชเทวี กรุงเทพฯ 10400

โทรศัพท์/โทรสาร 0-2201-1701 หรือ 0-2201-2504 หรือ 0-2201-0297